Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115568 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Asli Özkan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: a.oezkan@lumc.nl. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Quality of Life, Neoplasms, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Fonds Oncologie Holland, Leiden University Fund project, Leids Universitair Medisch Centrum.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: a.oezkan@lumc.nl.
- Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands; LUMC Center for Medicine for Older People, Leiden University Medical Center, Leiden, the…
- Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands.
- Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Förderung
- Stichting Fonds Oncologie Holland
- Leiden University Fund project
- Leids Universitair Medisch Centrum
- Universiteit Leiden
- ZonMw
Zitieren
APA
Özkan, A., de Joode, K., Kapiteijn, E., Slingerland, M., Zunder, S., van den Bos, F., Mooijaart, S., Uit den Boogaard, A., Trompet, S., Westgeest, H., van der Veldt, A., Mathijssen, R. H. J., Labots, G., Holterhues, C., Verdegaal, E. M. E., Tigges, T., Portielje, J. E. A., & de Glas, N. A. (2025). Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115568
Vancouver
Özkan A, de Joode K, Kapiteijn E, Slingerland M, Zunder S, van den Bos F, et al. Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115568
BibTeX
@article{zkan2025,
author = {Özkan, Asli and de Joode, Karlijn and Kapiteijn, Ellen and Slingerland, Marije and Zunder, Stephanie and van den Bos, Frederiek and Mooijaart, Simon and Uit den Boogaard, Anna and Trompet, Stella and Westgeest, Hans and van der Veldt, Astrid and Mathijssen, Ron H J and Labots, Geert and Holterhues, Cynthia and Verdegaal, Els M E and Tigges, Tessa and Portielje, Johanneke E A and de Glas, Nienke A},
title = {Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115568}
}
EUVIMED